rdf:type |
|
lifeskim:mentions |
umls-concept:C0000545,
umls-concept:C0014486,
umls-concept:C0020443,
umls-concept:C0021149,
umls-concept:C0021810,
umls-concept:C0022341,
umls-concept:C0023779,
umls-concept:C0041712,
umls-concept:C0221099,
umls-concept:C0441471,
umls-concept:C0596620,
umls-concept:C1280500,
umls-concept:C1367459,
umls-concept:C1522318,
umls-concept:C1522552,
umls-concept:C1705819
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-10-5
|
pubmed:databankReference |
|
pubmed:abstractText |
JELIS was a large-scale clinical trial that investigated the effects of eicosapentaenoic acid (EPA) on coronary artery disease (CAD). In this paper, the data of patients registered in JELIS were analysed to compare the incidence of CAD between patients with impaired glucose metabolism (IGM) and normoglycemic (NG) patients. The effect of EPA on the incidence of CAD in patients with IGM was also assessed.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1879-1484
|
pubmed:author |
pubmed-author:HishidaHitoshiH,
pubmed-author:IshikawaYuichiY,
pubmed-author:ItakuraHiroshigeH,
pubmed-author:KitaToruT,
pubmed-author:KitabatakeAkiraA,
pubmed-author:LeónL MLM,
pubmed-author:MatsuzakiMasunoriM,
pubmed-author:MatsuzawaYujiY,
pubmed-author:NakayaNoriakiN,
pubmed-author:OikawaShinichiS,
pubmed-author:OrigasaHidekiH,
pubmed-author:SaitoYasushiY,
pubmed-author:SakataToshiieT,
pubmed-author:SasakiJunJ,
pubmed-author:ShimadaKazuyukiK,
pubmed-author:ShiratoKunioK,
pubmed-author:YokoyamaMitsuhiroM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
206
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
535-9
|
pubmed:meshHeading |
pubmed-meshheading:19447387-Adult,
pubmed-meshheading:19447387-Aged,
pubmed-meshheading:19447387-Coronary Artery Disease,
pubmed-meshheading:19447387-Diabetes Mellitus,
pubmed-meshheading:19447387-Eicosapentaenoic Acid,
pubmed-meshheading:19447387-Female,
pubmed-meshheading:19447387-Humans,
pubmed-meshheading:19447387-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19447387-Hypercholesterolemia,
pubmed-meshheading:19447387-Japan,
pubmed-meshheading:19447387-Male,
pubmed-meshheading:19447387-Middle Aged
|
pubmed:year |
2009
|
pubmed:articleTitle |
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).
|
pubmed:affiliation |
Nippon Medical School, Department of Medicine, 1-1-5 Sendagi, Bunkyoku, Tokyo 113-8603, Japan. shinichi@nms.ac.jp
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|